A cross-lingual analysis on the spread of misinformation using the case of Ivermectin as a treatment for Covid-19

被引:1
|
作者
Lai, Cameron [1 ]
Toriumi, Fujio [1 ]
Yoshida, Mitsuo [2 ]
机构
[1] Univ Tokyo, Grad Sch Engn, Tokyo 1130033, Japan
[2] Univ Tsukuba, Inst Business Sci, Tokyo 1120012, Japan
关键词
D O I
10.1038/s41598-023-41760-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The spread of misinformation transgresses international boundaries, between languages and cultures. This is especially evident in times of global crises such as the Covid-19 pandemic. This study observes misinformation on Twitter in the Japanese and English languages regarding false claims that the drug Ivermectin is an effective treatment for Covid-19. Our exploratory cross-lingual analysis identifies key themes of discussion and influential users in both languages, finding English misinformation to be highly popular amongst Japanese users. Significantly, an analysis of the timing of retweets between languages reveals that Japanese users find and widely share English misinformation often before English users themselves. This contradicts expectations that users from other languages tend to pick up on popular misinformation in English. Instead, they seek out English language sources irrespective of their popularity to support their agenda. These results emphasise the importance of cross-lingual mitigation strategies for organizations trying to combat misinformation, and that they must look beyond their own language spheres.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] A cross-lingual analysis on the spread of misinformation using the case of Ivermectin as a treatment for Covid-19
    Cameron Lai
    Fujio Toriumi
    Mitsuo Yoshida
    Scientific Reports, 13
  • [2] Cross-lingual COVID-19 Fake News Detection
    Du, Jiangshu
    Dou, Yingtong
    Xia, Congying
    Cui, Limeng
    Ma, Jing
    Yu, Philip S.
    21ST IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOPS ICDMW 2021, 2021, : 859 - 862
  • [3] Spread of misinformation during COVID-19: The case of Mauritius
    Beebeejaun, Ambareen
    IFLA JOURNAL-INTERNATIONAL FEDERATION OF LIBRARY ASSOCIATIONS, 2023, 49 (02): : 345 - 356
  • [4] Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19
    Perlis, Roy H.
    Trujillo, Kristin Lunz
    Green, Jon
    Safarpour, Alauna
    Druckman, James N.
    Santillana, Mauricio
    Ognyanova, Katherine
    Lazer, David
    JAMA HEALTH FORUM, 2023, 4 (09): : E233257
  • [5] A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?
    Shafiee, Arman
    Teymouri Athar, Mohammad Mobin
    Mozhgani, Sayed-Hamidreza
    FUTURE VIROLOGY, 2023, 18 (03) : 137 - 139
  • [6] Ivermectin Treatment for Covid-19
    Furlan, Leonardo
    Mejia, Jorge H.
    Jimenez, Carlos A. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24):
  • [7] Ivermectin Treatment for COVID-19
    Ohe, Masashi
    EWHA MEDICAL JOURNAL, 2021, 44 (04): : 146 - 147
  • [8] COVID-19 and misinformation Is censorship of social media a remedy to the spread of medical misinformation?
    Niemiec, Emilia
    EMBO REPORTS, 2020, 21 (11)
  • [9] The Use of Ivermectin in the Treatment of COVID-19
    Shukla, Ajay Kumar
    Misra, Saurav
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (06) : 1554 - 1554
  • [10] Ivermectin as a potential treatment for COVID-19?
    Chosidow, Olivier
    Bernigaud, Charlotte
    Guillemot, Didier
    Giraudeau, Bruno
    Lespine, Anne
    Changeux, Jean-Pierre
    Bourhy, Herve
    Lecuit, Marc
    Amoura, Zahir
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (06):